0001628280-24-000693.txt : 20240105
0001628280-24-000693.hdr.sgml : 20240105
20240105172947
ACCESSION NUMBER: 0001628280-24-000693
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240104
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewis William
CENTRAL INDEX KEY: 0001402051
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30739
FILM NUMBER: 24517627
MAIL ADDRESS:
STREET 1: 10 FINDERNE AVENUE
STREET 2: BUILDING 10
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSMED Inc
CENTRAL INDEX KEY: 0001104506
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 541972729
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908-977-9900
MAIL ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: INSMED INC
DATE OF NAME CHANGE: 20000128
4
1
wk-form4_1704493778.xml
FORM 4
X0508
4
2024-01-04
0
0001104506
INSMED Inc
INSM
0001402051
Lewis William
700 US HIGHWAY 202/206
BRIDGEWATER
NJ
08807
1
1
0
0
Chair and CEO
0
Common Stock
2024-01-04
4
A
0
37869
A
380517
D
Common Stock
2024-01-05
4
S
0
6979
29.2585
D
373538
D
Common Stock
233924
I
By ARTICLE 4 KATIE PROCTER DYNASTY TRUST
Common Stock
500
I
By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020
Stock Option (right to buy)
29.13
2024-01-04
4
A
0
186970
0
A
2034-01-04
Common Stock
186970
186970
D
Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.
Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.
Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
This is the weighted average sales price representing 6,979 shares sold at prices ranging from $29.24 to $29.26 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.
/s/ William H. Lewis, by Michael Smith as Attorney in Fact
2024-01-05